At present, the continuous spread of the new crown pneumonia epidemic, the continuous mutation of the virus has brought continuous challenges to the prevention and control of the epidemic, and scientists around the world have also rapidly promoted the research related to the new crown pneumonia in various fields such as pathogens, vaccines, drugs, clinical and epidemiological diseases, and have continuously achieved new results and progress.
Today and tomorrow, the 2021 Shanghai Infectious Diseases Forum and Shenjiang Health Forum were held in Shanghai, and the forum sent out news: In the past year since the shanghai Institute of Major Infectious Diseases and Biosafety has been running, the Institute has been building while researching, integrating Shanghai's superior research forces and resources, focusing on the four directions of major infectious disease etiology and biosafety research and technology transformation, clinical trials and diagnosis and treatment of major infectious diseases, major infectious diseases and biosecurity big data and early warning prediction research, and major infectious diseases and biosecurity prevention and control strategies and policy research Strive to build a national comprehensive research center for infectious diseases, a scientific and technological guidance center for early warning and epidemic prevention and control, an international pathogenic qualitative standard for infectious diseases and the world's top comprehensive research institutions for infectious diseases and biosecurity, and contribute to the protection of people's health and urban public health security.
On November 30, 2020, the Shanghai Institute of Major Infectious Diseases and Biosafety was inaugurated at the Shanghai Medical College of Fudan University. The Shanghai Municipal People's Government and Fudan University signed an agreement to jointly establish the Shanghai Institute of Major Infectious Diseases and Biosafety. The establishment of the research institute is an important measure to implement the Shanghai Public Health Construction Conference and the Shanghai "20 Articles of Public Health Construction".
The forum is the first forum held by the Shanghai Institute of Major Infectious Diseases and Biosafety since its establishment. With the theme of "Research Progress of New Coronary Pneumonia", the forum focused on seven topics: covid-19 epidemiology and prevention, clinical characteristics and diagnosis and treatment of COVID-19, structure and receptor binding of SARS-CoV-2, invasion and replication, specific immune response, vaccine research and development, and vaccine protection effect. Experts and scholars from the frontline of infectious disease prevention and vaccine research and development at home and abroad and relevant practitioners participated in the conference online or offline to jointly contribute to the fight against the new crown epidemic.
Wu Fan, vice president of Shanghai Medical College of Fudan University, dean of Shanghai Institute of Major Infectious Diseases and Biosafety, and president of Shanghai Preventive Medicine Association, said that in the process of responding to previous epidemics, Shanghai has scientific prevention and control, precise prevention and control, and the Shanghai model of "early, fast, accurate and full warm" has been deeply rooted in the hearts of the people.
As an important measure to enhance the strength of public health science and technology and the capacity building of the public health system, the Shanghai Institute of Major Infectious Diseases and Biosafety is about to celebrate its first anniversary, and is rapidly promoting the construction of scientific research teams and the introduction of talents, accelerating the construction of a "full-chain" scientific research sharing platform and the construction of high-level biosafety laboratories, starting to launch the key core technology reserves for the prevention and control of major infectious diseases, and committed to building a "Shanghai platform, national network, and international alliance" for major infectious diseases and biosecurity research. It has truly become a strategic scientific and technological force of the state in the prevention and control of major infectious diseases and the field of biosecurity and guarantee.
Wu Jinglei, director of the Shanghai Municipal Health Commission, said that the forum provided a good platform for sharing experience in the fields of traditional infectious diseases, emerging infectious diseases and biosecurity research, exchanged research results on the prevention and control of infectious diseases, and played a positive role in promoting research in the field of infectious diseases, promoting Shanghai's economic and social development, and improving the people's health level. At present, the domestic epidemic prevention and control situation is still grim, and through this forum, the strength of all parties is gathered to further play an important role in scientific, accurate and timely prevention and control of the epidemic in Shanghai and the whole country, ensuring the smooth operation of Shanghai and the normal development of the economy and society.
Wen Yumei, an academician of the Chinese Academy of Engineering and a professor at the School of Basic Medical Sciences of Fudan University, said that the forum was participated in and supported by domestic and international experts from all walks of life, covering seven major topic discussions, involving a wide range of research fields, sharing successful experience in the process of comprehensive common anti-epidemic, and being a conference teacher in the field of infectious diseases and biosecurity research. She said bluntly, "We should not only exchange more about the research work we have done, but more importantly, jointly explore the direction of future scientific research, continue to contribute to basic research in the field of infectious diseases and biosecurity, and provide effective support for epidemic prevention and control." ”
At the same time, the reporter learned that Shanghai Pharmaceutical officially led the establishment of the "Frontier Industry Innovation Center" a few days ago, aiming to gather the resources of "famous enterprises, famous universities and famous institutes" in Shanghai's biomedical industry, establish an efficient link platform for basic scientific research and applied scientific research and industrialization of achievements, promote the original innovation of Chinese biomedicine, and explore a new ecological model for collaborative innovation in the industrial chain. I look forward to working with experts and scholars to jointly make new and greater contributions to the development of China's pharmaceutical industry and to the life, health and social well-being of the people.
The forum was hosted by Shanghai Institute of Major Infectious Diseases and Biosafety and Shanghai Preventive Medicine Association, and supported by Shanghai Pharmaceutical Cansino Biopharmaceutical Co., Ltd. At the forum site, experts and scholars from various research institutes at home and abroad, member units of the ASEAN Medical Education Alliance, medical colleges, disease prevention and control institutions at all levels, and front-line prevention and control backbones gathered online and offline, bringing more than 40 wonderful academic reports and sharing the academic feast of professional exchanges and thinking collisions. The forum topics focus on the hot spots and latest progress of new crown pneumonia research, aim at the major strategic needs of infectious disease prevention and control, and focus on pathogenic and epidemiological research and the latest epidemic prevention and control trends and vaccine research and development progress.
Column Editor-in-Chief: Gu Yong Text Editor: Gu Yong
Source: Author: Gu Yong